Market overview
The surgical robots market size was valued at USD 4.21 billion in 2021 and is expected to rise from USD 5.05 billion in 2022 to USD 21.41 billion by 2030, with a compound yearly growth rate (CAGR) of 5.8% over the forecast period (2022– 2030). Surgical robots are used for the manipulation of surgical instruments and are used in invasive surgery techniques. Globally, an enormous spike has been market in the last few years.
The rise inability of hospitals for investing in manufacturing surgical robots has helped in propelling up market growth. It has helped the doctors for carrying out all the necessary surgeries and has helped the patients complete the surgery and is very much convenient for carrying out certain procedures.
The high growth in technological advancement and high growth in invasive surgeries and highly investing in developing the innovative technologies have propelled the market size during the review period. The high growth in the adoption of medical technologies globally has boosted upmarket development in the upcoming years. Some of the factors like the high costs of surgical robots and the risks of dealing with the robot-associated surgeries have promoted the growth.
Market segmentation
The surgical robot market trend has been segmented based on type, application, control mechanism, and end-user segment. Based on product type, the instruments and accessories segment has helped in covering a huge market share during the forecast period. Based on the application segment, the surgery unit has flourished during the review period. Based on the control mechanism, the manipulation segment dominated during the review period. Based on the end-user segment, the hospital units has estimated in taking the most important position in the leading surgical segment.
Regional classification
The North American market has held a significant market share during the review period. It has anticipated governing the whole of the market thus owing to mounting up the ability of medical units, which has to capitalize on the systems and has planned acquisitions within other key players thus intensifying the usage for using robots in certain medical procedures which have helped in dominating the healthcare units.
The European region has been marked to cover a large share for Surgical Robots Market during the review period. The rise in market development has boosted the automation sectors in healthcare units and thus helping in mounting up the invasive surgeries and in making miniature surgeries. The Asia Pacific has been growing at a faster rate due to high growth in population, a high rise in the number of hospitals, and a rise in expansion in technology for supporting the development of the surgery market.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
Market Overview
In 2022, the Ultrasound Devices Market was valued at USD 10.8 billion. The ultrasound devices market is expected to increase from USD 11.2 billion in 2023 to USD 15.39 billion by 2032, with a compound annual growth rate (CAGR) of 4.1% over the forecast period (2023-2032).
Market Drivers
The global ultrasound devices market is anticipated to record substantial growth over the review timeframe. The growth of the market is being driven by the factors such as the surging requirement for minimally invasive diagnostics, increasing need for therapeutic devices, the launch of technically advanced equipment, and the growing trend towards home healthcare and remote patient monitoring. However, the market faces certain challenges such as lack of trained technicians and recent incidents of a product recall in the market.
Segment Analysis
The global market for ultrasound devices is divided into numerous segments based on portability, display, application, technology, end-user, and region.
The ultrasound devices market is divided into Point-Of-Care (POC), handheld/compact, and cart/trolley by portability. Based on the display, the global market is divided into black & white and color.
In application, the ultrasound devices market is split into neurology, musculoskeletal, urology, gastroenterology, cardiology, radiology/general imaging, vascular, anesthesiology, and obstetrics/gynecology. Based on technology, the market is divided into therapeutic ultrasound and diagnostic ultrasound.
By end-user, the global market is divided into research and academic institutes, maternity centers, ambulatory centers, and hospitals and diagnostic & surgical centers.
Regional Analysis
The global ultrasound devices market research is studied across five regions: Europe, North America, South America, Asia-Pacific, and the Middle East & Africa.
The growing incidents of chronic illness are driving the regional market’s growth, and increasing healthcare expenses among the expanding geriatric population are anticipated to accelerate the industry in the coming time.
The North American regional market is anticipated to secure the second position in the market globally over the review timeframe. The regional market’s growth is expected to be driven by the growing occurrence of chronic ailments among the expanding geriatric population. The presence of established players in the region is anticipated to be vital to boost market performance over the assessment timeframe.
The Asia-Pacific region is likely to record a substantial growth rate over the assessment timeframe. The regional market’s growth is primarily being driven by the increasing initiatives to improve the healthcare facilities. The rising occurrence of chronic ailments and the presence of developing countries such as India, China, and Japan are also likely to strengthen the performance of the regional market.
Competitive Analysis
The global ultrasound devices market has an intensely competitive landscape with a wide number of players spread worldwide. Numerous players in the market are adopting new strategies such as mergers, acquisitions, partnerships, product launches, and more. The list of leading players in the ultrasound devices market includes companies such as General Electric Company (U.S.), Trivitron Healthcare (India), Esaote Spa (Italy), Canon Medical Systems Corporation (Japan), Koninklijke Philips N.V. (The Netherlands), Analogic Corporation (U.S.), Fukuda Denshi (Japan), Shenzhen Mindray Bio-Medical Electronics Co. Ltd. (China), Siemens Healthineers (Germany), Shantou Institute of Ultrasonic Instruments Co. Ltd. (China), Fujifilm Holdings Corporation (Japan), Hitachi Ltd. (Japan), Samsung Electronics Co. Ltd. (South Korea), and others.
Recent Developments
October 2021- The U.S. healthcare subsidiary of Samsung, NeuroLogica Corp., has introduced a high-end ultrasound system that provides enhanced image quality, usability, and convenience for ultrasound professionals, the V8. The V8 was lately approved by the U.S. Food and Drug Administration for commercial use in the USA. The feature-packed device includes two latest artificial intelligence (A.I.) functions. The first is “NerveTrack™,” an exciting A.I. technology that senses nerves’ location during live scanning. The second is “UterineAssist,” which senses tissue changes and helps the user with measurements of the uterus.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
Market Overview:
The Glaucoma Surgery Market Size was assessed at USD 0.6 billion in 2022 and is expected to rise from USD 0.63 billion in 2023 to USD 1.3 billion by 2032, with a compound annual growth rate (CAGR) of 6.7% during the forecast period (2023-2032).
Glaucoma therapeutics refers to various treatment alternatives for primary open-angle and primary angle-closure glaucoma. The disease is characterized by structural changes in the optic nerves that lead to visual loss and blindness. The treatment for glaucoma can be initiated through topical eye drops, which majorly consist of beta-blockers, prostaglandin analogues, cholinergic, carbonic anhydrase inhibitors and alpha-adrenergic agonists. These eye drops minimize fluid production in the eyes, reducing intraocular pressure. This can be followed by traditional or laser surgical procedures, which use products such as implantable extended-release devices, polymer-based contact lenses, drug-eluting punctual plugs, micro needle-injection devices, and micro-dosing technologies.
The increasing prevalence of glaucoma across the globe represents one of the key factors driving the market’s growth. Glaucoma is highly prevalent in patients with diabetes and other eye disorders, such as age-related macular degeneration, cataract and dry eye. In line with this, the rising geriatric population, which is more susceptible to such ailments, creates a positive market growth outlook. Furthermore, increasing health consciousness among the masses and rising preference for laser glaucoma surgery also drive glaucoma surgery market trend. Additionally, the development of innovative combination dugs is acting as another growth-inducing factor. Pharmaceutical manufacturers are creating anti-glaucoma drugs and prostaglandin analogues combined with two or more drugs to control the elevated levels of IOP. Other factors, including the advent of advanced glaucoma diagnostic techniques and improvements in the healthcare infrastructure, are expected to drive the glaucoma surgery market further.
Market Segmentation:
The global market has been segmented into product outlook, method outlook, end-user outlook and regional sectors. Based on the product outlook, the global market is divided into 11 sections: punches, USC marker, USC planner, USC shaver, forceps, algerbrush, probes, diamond knives, glaucoma drainage devices, and laser systems, others. With the method outlook, the market is segmented into eleven sections: traditional glaucoma surgery, trabeculectomy, tube shunt, minimally invasive glaucoma surgery, trabecular meshwork bypass, and suprachoroidal space, sub conjunctional space implants, laser surgery, trabeculoplasty, iridotomy and cyclophotocoagulation. With the end-user outlook section, the market is segmented into hospitals, ophthalmic clinics and others. Based on the regional analysis, the global glaucoma surgery market is divided into five sections: Asia-Pacific, Europe, North America, South America, and the Middle East & Africa.
Regional Analysis:
North America is expected to hold a significant glaucoma surgery market in the global Glaucoma Surgery Devices Market due to the increasing prevalence of glaucoma, rising geriatric population, increasing awareness, favorable reimbursements policies, and several major players. As per a report published by Glaucoma Research Foundation, an estimate of 3 million people have glaucoma, and the number will increase in the coming years. Moreover, the growing number of geriatric populations in the United States is more prone to have glaucoma. Furthermore, increasing healthcare expenditure and the presence of well-established healthcare infrastructure are also fueling the growth of the overall regional market to a large extent.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
Dental CAD/CAM Market-Overview
The Dental CAM Milling Machine Market was valued at USD 1.1 billion in 2022. The Dental CAM Milling Machine market is expected to increase from USD 1.2 billion in 2023 to USD 2.4 billion by 2032, with a compound yearly growth rate (CAGR) of 9.3% over the forecast period (2023-2032).
The amplified employment of computer-aided manufacturing devices to improve the design is anticipated to lift the dental CAD/CAM market share in the impending period. Moreover, the high collective occurrence of dental diseases is foreseen to positively impact the dental CAD/CAM market in the forthcoming period.
Segmental Analysis
The segmental study of the dental CAD/CAM Milling Machine market has been conducted on the basis of product type, component, application, end-user, and region. On the basis of end-user, the market for dental CAD/CAM has been segmented into milling centers, dental laboratories, and dental clinics. Based on the product type, the market for dental CAD/CAM has been segmented into in-office and in-lab. On the basis of application, the market for dental CAM Milling Machine market share has been segmented into the dental prosthesis, material, and dental implant. On the basis of component, the market for dental CAD/CAM has been segmented into a milling machine, scanners, equipment, and software. On the basis of regions, the dental CAD/CAM market has been segmented into the Americas, the Middle East, Africa, Europe, and the Asia Pacific.
Detailed Regional Analysis
The regional appraisal of the dental CAD/CAM market is segmented into regions such as the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The European dental CAD/CAM market is anticipated to grasp the prime share of the global market for the duration of the forecast period. It is responsible for a 42.10% market segment. This can be accredited to the intensifying understanding of dental CAD/CAM, growing backing from the government, and the incidence of a huge geriatric population. The Americas’ dental CAD/CAM market is projected to hold the second leading market share all through the forecast period. The dynamics accountable for dental CAD/CAM market growth in this region are the growing incidences of dental illnesses and a huge number of dental service administrations.
Competitive Analysis
The end-users in the market are estimated to show variety in terms of the preference in the coming period. The decrease in supply chain bottlenecks is appraised as a primary objective that challengers in the market are assessed to tackle urgently in the forecast period. The prerequisite for sustainability in the market is projected to be formed by renewing the open cash movements. The Dental CAM Milling Machine Market report is estimated to open up to new and lucrative opportunities for expansion in the forecast period. The contenders for the majority share are predicted to transform the market backdrop considerably in the forecast period. The government bodies of several countries are likely to play a central role in the revitalization of the global market, post the deceleration seen in the aftermath of the pandemic. The markets are estimated to conduct more of their business dealings online than in brick and mortar stores.
The notable contenders in the Dental CAM Milling Machine Market are PLANMECA OY (Helsinki Finland), Danaher Corporation (US), Align Technology, Inc. (US), Straumann (UK), Roland DG Corporation (Japan), Dentsply Sirona (US), and DATRON AG (UK).
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
The surgical instrument tracking system market is growing pervasively. Market growth attributes to the rising demand for better inventory and asset management practice. Besides, the growing need to meet the compliance of unique device identification rules defined by the Food and Drugs Administration (FDA) drive the market growth. Moreover, the high adoption rate of surgical instrument tracking systems by hospitals escalates the market growth to furthered height.
The Surgical Instrument Tracking Systems Market size was valued at USD 0.25 billion in 2022 and is expected to rise from USD 0.278 billion in 2023 to USD 0.66 billion by 2032, with a compound annual growth rate (CAGR) of 11.5% between 2023 and 2032. Factors such as rising orthopedic, spinal, and dental procedures drive market growth. Also, increasing technological advances act as a significant driving force for the growth of the market. Besides, growing numbers of healthcare facilities accelerate market growth.
Digitalization in medical sectors is another significant growth driver for market growth. Also, the rapidly spreading awareness about the benefits of robotic procedures and rising healthcare expenses significantly boosts the size of the market. Additionally, the increasing number of ambulatory services and government initiatives & funding fosters the sales of surgical instrument tracking systems across the world.
Conversely, the high cost, lack of skilled professionals, and stringent regulatory policies are the major factors expected to obstruct the market growth. Nevertheless, the growing demand for capable and advanced devices and treatment procedures would support the growth of the market throughout the review period.
Global Surgical Instrument Tracking System Market – Segments
The report is segmented into four dynamics;
By System Type : Electronic Tracking, Barcode Tracking, Radio Frequency Identification (RFID), and others.
By Components : Software, Hardware (Readers, Tags, others), and Services.
By End User : Hospitals & Clinics, Research Centers, and others.
By Regions : Americas, Europe, Asia Pacific, and Rest-of-the-World.
Surgical Instrument Tracking System Market – Geographical Analysis
North America dominates the global surgical instrument tracking system market. The largest market share attributes to the rising demand for guided and robotic surgeries. Besides, the increasing surgical procedures and high R&D investments foster the growth of the regional market.
Europe stands second in the global surgical instrument tracking system market outlook. The market is driven by the rising rates of spinal, orthopedic, and neurosurgeries. Additionally, colossal spending on the manufacturing of medical & surgical devices influences market growth.
The surgical instrument tracking system market is brisk in the Asia Pacific region. Factors such as the rising numbers of orthopedic surgeries, especially in the growing older population, bolster the market growth. Moreover, significant developments in advanced technology and increasing awareness influence the growth of the regional market.
Considerable progress in medical sectors in emerging economies such as Japan, China, and India, are major driving forces behind the regional market growth.
Global Surgical Instrument Tracking System Market – Competitive Analysis
Fiercely competitive, the surgical instrument tracking system market appears fragmented due to the presence of several well-established players. To gain a larger competitive share, industry players incorporate strategic initiatives such as mergers & acquisitions, collaboration, and innovations.
For business expansion, they acquire small yet promising companies in the emerging markets, focusing on optimized situational awareness for customers.
Major Players:
Players leading the surgical instrument tracking system market report include Keir Surgical (Canada), Censis Technologies, Inc. (US), Microsystems, Inc. (US), Haldor Advanced Technologies (US), Becton, Dickinson and Company (US), Intelligent InSites (US), Mobile Aspects (US), Key Surgical (US), TGX Medical Systems (US), STANLEY Healthcare (US), Xerafy Singapore Pte Ltd (Singapore), Getinge AB (Sweden), Scanlan International (US), SpaTrack Medical Limited (UK), and FingerPrint Medical Limited (UK), and others.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
Neurovascular devices encompass a range of devices which are used for neurovascular management. The rise of neurovascular devices such as brain aneurysms, carotid artery disease, and others are likely to warrant of advanced devices which can prevent the possibility of strokes and other diseases. The global neurovascular devices market report by Market Research Future (MRFR) comprises a comprehensive analysis of the current state and future predictions for the period of 2012 to 2030 (forecast period).
Market Scope
Market Research Future (MRFR) predicts the Neurovascular Devices Market size to be worth more than USD 4.2 billion by 2030. MRFR also forecasts a 5.7% growth rate in the global market during the evaluation period (from 2022 to 2030). It is driven by the rise of neurovascular diseases and development of minimally invasive procedures.
Investments by government organizations for management of neurological conditions can bode well for the market. This is exemplified by the use of funds amounting to USD 6.6 billion by the NHS in the U.K. Clinical trials being conducted for new methods and procedures can encourage market growth. Endovascular treatments are gaining traction with many patients opting it as a method for acute ischemic stroke.
However, high procedural costs and lack of skilled physicians can dampen the market growth prospects.
Segmentation
The global neurovascular devices market is segmented by product, therapeutic application, and end-user.
On the basis of the product, the market is segmented into, aneurysm coiling & embolization devices, neurothrombectomy devices, cerebral balloon angioplasty and stenting systems, and support device. Aneurysm coiling & embolization devices are sub-segmented into liquid embolic, embolic coils, and flow diversion devices. Embolic coils, a part of aneurysm coiling & embolization devices segment, are further segmented into detachable coils and pushable coils. Similarly, neurothrombectomy devices segment is sub-segmented into suction and aspiration devices and retrieval systems. The support device segment is sub-segmented into microcatheters and microguidewires. The cerebral balloon angioplasty and stenting systems segment is sub-segmented into carotid artery stents and embolic protection systems. Embolic protection systems are further divided into distal filter devices and balloon occlusion devices.
By therapeutic application, the global neurovascular devices market is categorized into hemorrhagic stroke and ischemic strokes.
By end-users, the market is segmented into hospitals & clinics and ambulatory surgical units.
Regional Analysis
The Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa are regions considered for measuring the value and volume of the global neurovascular devices market.
The Americas are touted to dominate the global neurovascular devices market owing to high prevalence of neurovascular diseases. According to a study by the Methodist DeBakey Cardiovascular Journal in 2014, close to 1 million strokes occur annually due to intracranial atherosclerotic disease. The large healthcare expenditure of nations in the region and presence of major players can further regional market growth.
APAC is predicted to exhibit a stellar growth rate during the forecast period owing to the growth of economies of China and India. Demand for minimally invasive surgeries by the geriatric populace can fuel the demand in the global neurovascular devices market trend.
Competitive Outlook
Evasc, OxfordEndovascular, Gynesonics, Delaware Corporation, TERUMO CORPORATION, Merit Medical Systems, Inc., Secant Group, LLC, Rapid Medical, Neuravi, Medikit co., ltd., Stryker, Abbott, MicroPort Scientific Corporation, W. L. Gore & Associates, Inc., Medtronic, Penumbra, Inc., Johnson & Johnson Services, Inc., Blockade Medical, LLC., and Sensome are major players of the global neurovascular devices market. Product launches, acquisitions, and distribution agreements are strategies being implemented by players to sustain their position in the market. In 2020, Arterio Medical submitted the results of the clinical trial of Endura Embolization System in bifurcation systems. The results demonstrated the low relapse of coils and provide immediate cerebral aneurysm occlusion.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
Market Scope
Healthcare Biometrics Market Size was valued at USD 19.2 billion in 2022. The Healthcare Biometrics market is expected to increase from USD 23.4816 billion in 2023 to USD 79.2 billion by 2032, with a compound yearly growth rate (CAGR) of 22.1% over the forecast period (2023-2032). We will provide COVID-19 impact analysis with the report, along with all the extensive key developments in the market post the coronavirus disease outbreak.
Key Boosters and Deterrents
The uptake of biometrics in the healthcare industry to authenticate the staff and patients has snowballed notable in recent years. The COVID-19 outbreak has made people cautious about touching card readers, keypads, and devices that facilitate identity authentication; a favorable aspect for the market. Technologies, such as facial and iris recognition are observing even more demand following the onset of SARS-CoV-2, in line of the increasing use of online healthcare services due to the worldwide lockdown.
Keeping aside the pandemic aspect, the market has already been on an upward trajectory in the past few years, thanks to the expanding IT application scope in the healthcare sector coupled with the mounting awareness about the benefits of biometrics. Cybercrimes and their increasing superiority has been a cause of concern in not only the healthcare industry, but across various sectors.
Technological innovations by leading firms, with increasing focus on multipurpose authentication devices as well as upgradation of older technologies along with new product launches are anticipated to induce substantial market growth in the ensuing years. A case in point, in August 2020, WITHmyDOC, a Floridian healthcare tech firm launched RPM@Home, which is a RPM/remote patient monitoring kit. This kit makes use of an advanced intelligence platform to administer patients and then send out real-time biometric information to the healthcare professionals.
Segmental Insight
Technology, application and end-users are the top segments on the basis of which the overall market has been dissected in the MRFR study.
Healthcare biometrics market, depending on the technology segment, has been considered for fingerprint recognition, face recognition, behavioral recognition, vein recognition, palm geometry recognition, iris recognition, and more.
Data security, medical record management, patient identification, patient monitoring, and others are the key applications of healthcare biometrics.
The top industry end users identified in the report include healthcare institutes, research laboratories, hospitals, and more.
Regional Outlook
North America along with the Middle East and Africa/MEA, Europe and Asia Pacific/APAC are the primary markets for healthcare biometrics.
North America is presently the market leader and can gain further impetus over the coming years. The chief factors cited for the market growth include the alarming spike in the number of fraudulent activities and cybercrimes, which has prompted an increase in the use of advanced biometrics. The expanding number of new and smart healthcare establishments like clinics and hospitals, especially across Canada and the United States can also be an important growth enhancer in the North American market.
The healthcare biometrics market research in Europe is quite lucrative, given the consistent growth in digitization of the healthcare industry and the consequent surge in data breach cases observed over the years.
The APAC is on the way to attract the highest growth pace in the global market, as a result of the strong government support and the expanding IoT application scope in the healthcare sector. The rapid healthcare IT advancements combined with the increasing uptake of advanced digital patient monitoring systems has also added to the market attractiveness.
Renowned Companies
Some of the most renowned companies across the worldwide market include Morpho (A Subsidiary of Safran SA), BioEnable Technologies, Bio-Key International Inc., Integrated Biometrics, Fujitsu Limited, Imprivata Inc., 3M Cogent Inc., NEC Corporation, Suprema Inc., Crossmatch Technologies Inc., to name a few.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
Market Highlights
The Migraine Market Size was evaluated at USD 1.8 billion in 2022, and it is expected to expand from USD 1.9 billion in 2023 to USD 2.2 billion by 2030, with a compound annual growth rate (CAGR) of 3.10% between 2023 and 2030.
The influences driving target demand development include the growing knowledge of novel drug groups and the rising occurrence of migraine problems across the globe. Furthermore, the launch of calcitonin-related gene peptide (CGRP) is expected to accelerate this industry’s production.
Rising migraine prevalence is pushing the demand for migraine medications. In addition , the rise in the female population and the increase in awareness among patients about migraine prevention and care are main factors that accelerate market growth. It is due to increases in female oestrogen levels , especially during menstruation.
In comparison, prescription treatments, such as oral contraceptives and hormone replacement therapy, can further intensify migraine in women. Increasing the global female population is also projected to accelerate the development of the demand for migraine drugs.
Nevertheless, a consideration that hinders market demand is the adverse effects associated with migraine medications. On the contrary, the presence of opportunities for growth in emerging nations is expected to offer the key players new opportunities. The disease results from inherited history.
Market Scope
Improved awareness-raising campaigns, the availability of research funds from both private and public bodies, enhanced reimbursement scenario for related drugs and increasing understanding of the efficacy of these drugs are among the main factors driving the development of the Migraine Drugs sector.
The move from conventional symptomatic medications to new disease-specific therapies is apparent in the R&D pipeline, as most drug candidates tackle unmet needs in migraine treatment. This is known that there are three new drugs in the late stage pipeline which are expected to change the healthcare system in the immediate future.
Market Segmentation
The Global market is majorly segmented based on treatment types, types, and drug class.
Based on the type, the global Migraine market share is bifurcated into episodic and chronic.
Based on treatment types, the global Migraine market is classified into preventive and abortive.
Further, based on drugs, the Migraine market is classified into triptans, ergots, and others.
Regional Overview
The North America, Asia Pacific (APAC), Europe , the Middle East, and Africa (MEA), and Latin America (LATAM) segmented the market regionally.
In terms of geography North America dominates the market.
It is expected that a increase in vendor attention on developing markets such as Asia-Pacific and Middle East , and Africa and Latin America would fuel business growth.
Asia-Pacific is expected to see substantial growth in the future as a result of rising competition for quality healthcare facilities and improved health infrastructure. This field also provides exceptional prospects for venture capitalists and developers when the existing markets are largely saturated. However, China and India are the largest developed countries contributing to the development of the overall demand for migraine drugs in the Asia Pacific region; this is largely due to the high prevalence of migraine market insights in these nations. Growing emphasis on specialty medicines and their releases along with high competition from innovative drug manufactures would also have a positive effect on the development of the worldwide demand for migraine drugs in the near futureAsia-Pacific is projected to see significant growth in the future due to increased demand for better health facilities and improved health infrastructure..
Competitive Dashboard
The significant players listed in the market research report include Impax Laboratories, OptiNose, Abbott Laboratories, Inc., Allergan, Eli Lilly and Company, Pfizer, Inc., Eisai Inc., Johnson & Johnson, Kowa Pharmaceuticals America, Klaria, Luitpold Pharmaceuticals, Meda, Merck, AstraZeneca plc, and GlaxoSmithKline plc.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
Market Drivers
The Ulcerative Colitis Market Size was evaluated at USD 7.2 billion in 2022 and is expected to rise from USD 7.5744 billion in 2023 to USD 10.77 billion by 2032, with a compound annual growth rate (CAGR) of 5.1% over the forecast period (2023-2032).
Ulcerative colitis refers to inflammatory bowel disease (IBD), which affects the colon and rectum part of the human body. Ulcers and inflammation are formed in the innermost lining of the rectum and colon, causing the release of mucous and pus in these linings. Rectal bleeding, diarrhea, and abdominal cramps are the most common symptoms seen in people suffering from the disease.
The global ulcerative colitis market has been witnessing massive growth over recent years. The market’s growth is primarily being driven by the growing prevalence of ulcerative colitis disease that affects millions of people globally. Furthermore, the rise in government and non-government organizations towards research in biologics and the massive R&D and investment done by key players to develop novel therapies for UC treatment are some of the factors playing a salient role in the growth of the ulcerative colitis market outlook. However, the market growth is likely to be restricted by the stringent government regulations towards approval of biosimilars and patent expiry of drugs.
Segment Analysis
The global ulcerative colitis market is divided into numerous segments based on disease type, route of administration, molecular type, and region. By route of administration, the global market for ulcerative colitis is divided into injectables and oral.
The global market is bifurcated by disease type into severe ulcerative colitis, moderate ulcerative colitis, and mild ulcerative colitis. Based on molecular type, the global ulcerative colitis market is divided into biologics and small molecules.
Regional Analysis
The global ulcerative colitis market is studied across five major regions: North America, South America, Asia-Pacific, Europe, and the Middle East & Africa.
The North American regional market for ulcerative colitis is projected to hold the top position globally. The growth primarily drives the regional market’s growth due to the prevalence of sophisticated healthcare infrastructure. Furthermore, rapid adoption of new and better healthcare technologies and the growth in research and development proficiencies by the pharmaceutical companies are also expected to catalyze the regional market’s growth over the review timeframe. Additionally, the increasing prevalence of ulcerative colitis across the region is also playing a vital part in the regional market’s growth.
The Asia-Pacific region is expected to project the maximum growth rate over the review timeframe. The growing expenditure is driving the growth of the regional timeframe to develop healthcare infrastructure and the increasing involvement of regulatory bodies for research and development activities.
Competitive Analysis
The global market for ulcerative colitis has an intensely competitive landscape with many players spread worldwide. The players in the market are adopting several new strategies such as mergers, acquisitions, and more to grow their businesses. The list of leading players in the ulcerative colitis market report includes Ferring B.V., Pfizer Inc., UCB S.A., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services, Inc., Bayer AG, Perrigo Company plc, AbbVie Inc., Allergan, Inc., and several others.
Recent Developments
In May 2021- Bristol Myers Squibb got approval from the U.S. FDA for Zeposia (ozanimod) used for the treatment of adults with mildly to severely active ulcerative colitis (UC), a chronic inflammatory bowel disease (IBD).
April 2021- Arena Pharmaceuticals, Inc. started a phase II clinical trial to regulate whether oral etrasimod is a harmless and effective treatment for moderately active ulcerative colitis in adult participants. The trial is anticipated to finish in May 2023.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
Stem cell reconstructive surgery involves the use of stem cells for the regeneration of injured or damaged cells in the body. Continued support by government research organizations and funding by them will explore its potential in the treatment of various diseases. The stem cell reconstructive market size is estimated to grow at a 20.6% CAGR between 2022 and 2030, reaching USD 4,673.3 million.
Market Scope
The global stem cell reconstructive market is predicted to expand at 22.6% CAGR during the forecast period. Primary growth drivers include the large geriatric population, increasing incidence of patients suffering from chronic diseases, and constant developments in stem cell technology. Large healthcare expenditure of nations and need for alternative treatments can spur the market growth. Product developments have constantly disrupted the market. For instance, NuVasive launched the next generation bone graft, Attrax Putty, for U.S. customers. It has shown remarkable progress in spinal surgeries according to clinical trials by the company.
Large strides made in tissue engineering and establishment of stem cell banks can further the potential of the market. This can be used in testing of new products and conduction of clinical trials. Development of polymetric biomaterial systems as well automation of stem cell technologies will guide the market throughout the forecast period.
High costs of the treatment and strict rules against its application may hamper the global stem cell reconstructive market growth.
Segmentation
The global stem cell reconstructive market trend is segmented by sources, cell types, applications, and end users.
On the basis of sources, the market is categorized into syngeneic, allogeneic, autologous, and others. Autologous is further segmented into blood, bone marrow, and adipose tissue.
By cell types, the market is segmented into embryonic stem cell and adult stem cell.
On the basis of application the market is segmented into severe burn, cancer, diabetes, traumatic skin defect, and others.
On the basis of end users, the market is segmented into research institutes, hospital, and others.
Regional Analysis
The global stem cell reconstructive market report covers the trends and happenings to affect the market across the regions of Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).
The Americas accounted for the largest market share due to a well developed healthcare sector and a large patient pool. The major share of the region is held by North America owing to large number of patients in Canada and the U.S. High prevalence of cancer and diabetes can facilitate regional market growth.
Europe has assumed the second position in the global stem cell reconstructive market followed by APAC. Investments in stem cell research and identification of new cell cultures will boost the regional stem cell reconstructive market. Regulation of stem cell research in countries as well as funding for stem cell embryonic cells can drive the market.
APAC is a developing region for the market with the major demand for stem cell reconstructive surgeries coming from Japan and Australia. Emergence of stem cell suppliers in China, Australia, and India is evidence of the large potential of the global stem cell reconstructive market. Public-private partnership agreements as well as expanding product pipelines in cell-based research can facilitate market growth.
Competitive Outlook
TAKARA BIO INC., STEMCELL Technologies Inc., Cytori Therapeutics Inc., Celyad, Astellas Pharma US, Inc., Micronit Microfluidics, Capricor Therapeutics, NuVasive Inc., Baxter, Eleveflow, Pfizer Inc., Cynata, Tigenix, Mesoblast Ltd., Osiris Therapeutics, Inc., StemCells Inc, and Caladrius are some of the notable players profiled in the global stem cell reconstructive market.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com